- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Continuation of Routine Screenings, Care Is Crucial During COVID-19 Pandemic
On this episode of Managed Care Cast, Andrea Gelzer, MD, senior vice president and corporate chief medical officer for AmeriHealth Caritas, discusses the vital role telehealth has played during the pandemic, and how providers and payers can work together to encourage patients to continue routine care.
Routine preventive screenings and vaccination rates have decreased due to the coronavirus disease 2019 (COVID-19) pandemic, while the director of the National Cancer Institute recently warned delays in cancer screenings are likely to result in thousands of excess deaths. At the same time, a recent study found the pandemic could create losses of up to $15 billion for primary care practices.
To find out what can be done about these setbacks, and to learn why it is so critical to continue screenings during the pandemic, we spoke with Andrea Gelzer, MD, senior vice president and corporate chief medical officer for AmeriHealth Caritas.
On this episode of Managed Care Cast, Gelzer discusses the vital role telehealth has played during the pandemic, and how providers and payers can work together to encourage patients to continue routine care.
Listen above or through one of these podcast services:
Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care
February 25th 2025On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.
Listen
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
